Insider · CIK 0001365831
Michael C James
Files at GTHP (GUIDED THERAPEUTICS INC), LUXH (LUXURBAN HOTELS INC.). First filing Apr 8, 2025, latest Sep 5, 2025.
Michael C James files SEC Form 4 as CFO and director at GTHP (GUIDED THERAPEUTICS INC), and also at LUXH (LUXURBAN HOTELS INC.). Since Apr 8, 2025, Michael C James has reported 2 open-market buys worth $46k and 0 open-market sells worth $0, the latest filed on Sep 5, 2025.
A track record needs three past buys with six months of prices behind them; Michael C James has 0, so none is measured yet.
The newest scored trade: bought $5,000 of GTHP on Aug 29, 2025, filed Sep 5, 2025, scored 26 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GTHP: GUIDED THERAPEUTICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | GUIDED THERAPEUTICS INC | $5,000 27,778 shares | +5% | - | |
| 39Weak | GUIDED THERAPEUTICS INC | $41k 412,945 shares | +366% | - |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Stock Optionsderivative | +110,000 | $0.00 | $0 | 110,000 | Apr 7, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | XIn-the-money exercise Common Stock | +100,000 | - | - | 653,495 | Mar 4, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | -100,000 | - | - | 0 | Mar 4, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | +100,000 | - | - | 100,000 | Mar 4, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | -100,000 | - | - | 0 | Mar 4, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | JOther Warrantsderivative | +100,000 | - | - | 152,778 | Mar 4, 2026 |
| Feb 25, 2026 | GTHP GUIDED THERAPEUTICS INC | XIn-the-money exercise Warrantsderivative | -100,000 | - | - | 52,778 | Mar 4, 2026 |
| Aug 29, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Common Stock | +27,778 | $0.18 | $5,000 | 553,495 | Sep 5, 2025 |
| Aug 29, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Warrantsderivative | +27,778 | - | - | 52,778 | Sep 5, 2025 |
| Jun 3, 2025 | GTHP GUIDED THERAPEUTICS INC | AGrant or award Stock Optionsderivative | +110,000 | $0.00 | $0 | 110,000 | Jun 13, 2025 |
| Mar 18, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Common Stock | +150,000 | $0.10 | $15k | 262,772 | Apr 8, 2025 |
| Mar 18, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Common Stock | +262,945 | $0.10 | $26k | 525,717 | Apr 8, 2025 |
| Mar 18, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Warrantsderivative | +150,000 | - | - | 150,000 | Apr 8, 2025 |
| Mar 18, 2025 | GTHP GUIDED THERAPEUTICS INC | POpen-market purchase Warrantsderivative | +262,945 | - | - | 412,945 | Apr 8, 2025 |
| Nov 21, 2024 | LUXH LUXURBAN HOTELS INC. | AGrant or award Common Stock | +38,571 | $0.00 | $0 | 61,784 | Nov 22, 2024 |
Questions about Michael C James
Answered from the filings on this page, as of the latest one.
Is Michael C James buying or selling?
Not in the last 12 months. Michael C James's latest open-market trade on SEC Form 4 was bought $5,000 of GTHP on Aug 29, 2025.
How did Michael C James's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael C James has 0.
Where does Michael C James file Form 4?
Michael C James has filed Form 4 at GTHP (GUIDED THERAPEUTICS INC); LUXH (LUXURBAN HOTELS INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.